Acceleration of Tuberculosis Treatment by Adjunctive Therapy with Verapamil as an Efflux Inhibitor

Successful Shortening of Tuberculosis Treatment Using Adjuvant Host-Directed Therapy with FDA-Approved Phosphodiesterase Inhibitors in the Mouse Model

(2012) Mamoudou Maiga et al.   PLoS One

Contribution of Efflux to the Emergence of Isoniazid and Multidrug Resistance in Mycobacterium tuberculosis

(2012) Diana Machado et al.   PLoS One

Modeling early bactericidal activity in murine tuberculosis provides insights into the activity of isoniazid and pyrazinamide

(2012) J. Grosset et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pharmacokinetics of verapamil and its metabolite norverapamil in rats with hyperlipidaemia induced by poloxamer 407

(2012) Young Sun Lee et al.   XENOBIOTICA

Rifampicin Reduces Susceptibility to Ofloxacin in Rifampicin-resistantMycobacterium tuberculosisthrough Efflux

(2011) Gail E. Louw et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Drug Tolerance in Replicating Mycobacteria Mediated by a Macrophage-Induced Efflux Mechanism

(2011) Kristin N. Adams et al.   CELL

Mouse Model of Necrotic Tuberculosis Granulomas Develops Hypoxic Lesions

(2011) Jamie Harper et al.   JOURNAL OF INFECTIOUS DISEASES

Human Antimicrobial Peptide LL-37 Induces MefE/Mel-Mediated Macrolide Resistance in Streptococcus pneumoniae

(2010) D. Zahner et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Determination of doxazosin and verapamil in human serum by fast LC–MS/MS: Application to document non-compliance of patients

(2010) Lukáš Chytil et al.   JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES

Paradoxical Effect of Isoniazid on the Activity of Rifampin-Pyrazinamide Combination in a Mouse Model of Tuberculosis

(2009) D. Almeida et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Noninvasive Pulmonary [18F]-2-Fluoro-Deoxy-D-Glucose Positron Emission Tomography Correlates with Bactericidal Activity of Tuberculosis Drug Treatment

(2009) S. L. Davis et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of the Mycobacterium tuberculosis P55 Efflux Pump in Intrinsic Drug Resistance, Oxidative Stress Responses, and Growth

(2009) S. Ramon-Garcia et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view

(2009) Carleitta Paige et al.   CELLULAR MICROBIOLOGY

Efflux-Mediated Drug Resistance in Bacteria

(2009) Xian-Zhi Li et al.   DRUGS

Microarray Analysis of Efflux Pump Genes in Multidrug-Resistant Mycobacterium tuberculosis During Stress Induced by Common Anti-Tuberculous Drugs

(2009) Anuj Kumar Gupta et al.   Microbial Drug Resistance

Voltage Gated Calcium Channels Negatively Regulate Protective Immunity to Mycobacterium tuberculosis

(2009) Shashank Gupta et al.   PLoS One

Mycobacterium tuberculosisSigma Factor E Regulon Modulates the Host Inflammatory Response

(2008) Patricia A. Fontán et al.   JOURNAL OF INFECTIOUS DISEASES